<DOC>
	<DOCNO>NCT01876303</DOCNO>
	<brief_summary>This clinical trial study genetic biomarkers saliva sample patient Ewing sarcoma . Studying sample saliva patient cancer laboratory may help doctor learn change occur deoxyribonucleic acid ( DNA ) identify biomarkers related cancer .</brief_summary>
	<brief_title>Genetic Biomarkers Saliva Samples From Patients With Ewing Sarcoma</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To determine association length Ewing sarcoma breakpoint region 1-Friend leukemia virus integration 1 ( EWS-FLI1 ) fusion protein bind site ( microsatellites ) risk Ewing 's sarcoma ( ES ) . II . To determine frequency commonality Caucasian ancestral marker case ES self-identified non-Caucasian ( African-American , Asian , Hispanic ) . III . To determine association genomic variant ES-related gene hernia development ( i.e . integrin signal pathway ) risk ES . OUTLINE : Genomic DNA extract participant ' saliva sample analyze expression EWS-FLI1 ES-target gene .</detailed_description>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Neuroectodermal Tumors</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive</mesh_term>
	<mesh_term>Neuroectodermal Tumors , Primitive , Peripheral</mesh_term>
	<criteria>The patient enrol ACCRN07 The patient diagnosis Ewing Sarcoma ( International Classification Diseases [ ICD ] code morphology 9260 ; topography C40.0C41.9 , C76.0C76.8 , C80.9 ) register Children 's Oncology Group ( COG ) North American member institution The patient must diagnose Ewing sarcoma December 24 , 2007 December 31 , 2015 The patient must least one biological parent alive willing participate All questionnaire respondent must understand English Spanish Concomitant treatment therapeutic trial require</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>